Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krystallia Gourlia

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Clinical Medicine|September 23, 2020
Accurate Blood-Based Diagnostic Biosignatures for Alzheimer's Disease via Automated Machine LearningMakrina Karaglani, Krystallia Gourlia, Ioannis Tsamardinos, et al.
Machine Learning|October 30, 2023
Learning biologically-interpretable latent representations for gene expression data: Pathway Activity Score Learning AlgorithmIoulia Karagiannaki, Krystallia Gourlia, Vincenzo Lagani, et al.
Cancers|August 14, 2025
MicroRNA Expression Analysis and Biological Pathways in Chemoresistant Non-Small Cell Lung CancerChara Papadaki, Maria Mortoglou, Aristeidis E Boukouris, et al.
Plos One|June 1, 2021
Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution studyKonstantinos Rounis, Dimitrios Makrakis, Chara Papadaki, et al.
Plos One|November 9, 2023
Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution studyKonstantinos Rounis, Dimitrios Makrakis, Chara Papadaki, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Clinical Medicine|September 23, 2020
Accurate Blood-Based Diagnostic Biosignatures for Alzheimer's Disease via Automated Machine LearningMakrina Karaglani, Krystallia Gourlia, Ioannis Tsamardinos, et al.
Machine Learning|October 30, 2023
Learning biologically-interpretable latent representations for gene expression data: Pathway Activity Score Learning AlgorithmIoulia Karagiannaki, Krystallia Gourlia, Vincenzo Lagani, et al.
Cancers|August 14, 2025
MicroRNA Expression Analysis and Biological Pathways in Chemoresistant Non-Small Cell Lung CancerChara Papadaki, Maria Mortoglou, Aristeidis E Boukouris, et al.
Plos One|June 1, 2021
Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution studyKonstantinos Rounis, Dimitrios Makrakis, Chara Papadaki, et al.
Plos One|November 9, 2023
Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution studyKonstantinos Rounis, Dimitrios Makrakis, Chara Papadaki, et al.
Pageof 1